SVCM
Saturn V Capital Management’s KalVista Pharmaceuticals KALV Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $710K | Sell |
62,793
-192,267
| -75% | -$2.17M | 0.29% | 23 |
|
|
2025
Q1 | $2.94M | Sell |
255,060
-301,429
| -54% | -$3.48M | 1.49% | 17 |
|
|
2024
Q4 | $4.71M | Hold |
556,489
| – | – | 1.85% | 16 |
|
|
2024
Q3 | $6.44M | Sell |
556,489
-571,989
| -51% | -$6.62M | 2.3% | 17 |
|
|
2024
Q2 | $13.3M | Sell |
1,128,478
-313,474
| -22% | -$3.69M | 5.02% | 10 |
|
|
2024
Q1 | $17.1M | Sell |
1,441,952
-365,611
| -20% | -$4.34M | 6.86% | 4 |
|
|
2023
Q4 | $22.1M | Sell |
1,807,563
-2,683
| -0.1% | -$32.9K | 8.48% | 3 |
|
|
2023
Q3 | $17.4M | Buy |
1,810,246
+397,910
| +28% | +$3.83M | 7.3% | 2 |
|
|
2023
Q2 | $12.7M | Buy |
1,412,336
+290,354
| +26% | +$2.61M | 7.05% | 6 |
|
|
2023
Q1 | $8.82M | Buy |
1,121,982
+402,045
| +56% | +$3.16M | 6.59% | 9 |
|
|
2022
Q4 | $6.7M | Buy |
+719,937
| New | +$6.7M | 5.56% | 11 |
|